Is Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

CDT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 34.74%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,447,018.19

Conduit Pharmaceuticals Insider Trading History Chart

Conduit Pharmaceuticals Share Price & Price History

^$0.07

▲ +0.0091 (13.87%)

As of 12/20/2024 06:51 PM ET

Days: 30 | 90 | 365

Missed Nvidia? Buy Elon Musk’s “Silent Partner”

From Brownstone Research | Ad

In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.

So please click here to see the details because a lot of people could get rich.

Conduit Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/7/2024	Ltd Nirland	Major Shareholder	Sell	939,009	$0.10	$93,900.90	6,092,000
10/4/2024	Ltd Nirland	Major Shareholder	Sell	1,368,991	$0.10	$136,899.10	7,031,009
10/2/2024	Ltd Nirland	Major Shareholder	Sell	333,177	$0.10	$33,317.70	9,900,000
9/30/2024	Ltd Nirland	Major Shareholder	Sell	1,016,823	$0.12	$122,018.76	11,483,177
7/17/2024	Andrew Regan	Director	Sell	1,514,100	$0.26	$393,666.00	177,627
7/15/2024	Andrew Regan	Director	Sell	1,005,200	$0.25	$251,300.00	11,936,119
7/12/2024	Andrew Regan	Director	Sell	1,389,820	$0.25	$347,455.00	12,941,319
7/10/2024	Andrew Regan	Director	Sell	150,000	$0.33	$49,500.00	15,214,091
7/8/2024	Andrew Regan	Director	Sell	35,923	$0.51	$18,320.73	15,441,772
7/3/2024	Andrew Regan	Director	Sell	1,000	$0.64	$640.00	15,477,695

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

SEC Filings (Institutional Ownership Changes) for Conduit Pharmaceuticals (NASDAQ:CDT)

3.29% of Conduit Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Today's Range

Now: $0.07

$0.06

$0.08

50 Day Range

MA: $0.10

$0.07

$0.13

52 Week Range

Now: $0.07

$0.06

$5.51

Volume

18,690,658 shs

Average Volume

10,031,876 shs

Market Capitalization

$7.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.21

Who are the company insiders with the largest holdings of Conduit Pharmaceuticals?: Conduit Pharmaceuticals' top insider investors include:
Andrew Regan (Director)
Ltd Nirland (Major Shareholder)
Learn More about top insider investors at Conduit Pharmaceuticals.